SG Americas Securities
LOXO

SG Americas Securities’s Loxo Oncology, Inc LOXO Stock Holding History

SG Americas Securities’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-7,220
Closed -$1.01M – 3769
2018
Q4 		$1.01M Buy
7,220
+5,956
+471% +$904K 0.01% 1315
2018
Q3 		$216K Sell
1,264
-3,068
-71% -$516K ﹤0.01% 2527
2018
Q2 		$752K Buy
4,332
+2,760
+176% +$415K 0.01% 1698
2018
Q1 		$181K Buy
1,572
+171
+12% +$18.2K ﹤0.01% 2496
2017
Q4 		$118K Sell
1,401
-5,370
-79% -$448K ﹤0.01% 2771
2017
Q3 		$624K Buy
6,771
+3,924
+138% +$305K 0.01% 1648
2017
Q2 		$228K Buy
+2,847
New +$158K ﹤0.01% 2330
2017
Q1 		– Sell
-8,595
Closed -$276K – 3702
2016
Q4 		$276K Buy
+8,595
New +$220K ﹤0.01% 2104

Other funds holding LOXO

IUHSA
Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

SG Americas Securities's LOXO Position: Q1 2019 in Review

SG Americas Securities sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 7,220 shares — an estimated $1.01M sold.

SG Americas Securities first reported a position in LOXO in Q4 2016 and held it in 8 quarters. The position peaked at $1.01M in Q4 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

  • SG Americas Securities reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
  • SG Americas Securities sold 7,220 Loxo Oncology, Inc shares in Q1 2019, an estimated $1.01M.
  • SG Americas Securities first reported a position in Loxo Oncology, Inc in Q4 2016 and held it in 8 quarters.
  • SG Americas Securities's Loxo Oncology, Inc position peaked at $1.01M in Q4 2018.
  • 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on SG Americas Securities's 13F filing for Q1 2019, filed 29 Apr 2019.